Patient Guide: A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 21 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06122649
Status: ACTIVE_NOT_RECRUITING
Condition: Plaque Psoriasis
Phase: PHASE3

Where You Can Participate

This study is available at 21 locations across the country.

Top locations include:
  • • Beijing, Beijing Municipality
  • • Beijing, Beijing Municipality
  • • Fuzhou, Fujian
  • • And 18 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO) - Join Clinical Trial NCTNCT06122649

How to Join This Clinical Trial - NCTNCT06122649

Learn how to participate in this PHASE3 trial studying an investigational therapy for Plaque Psoriasis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Plaque Psoriasis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Plaque Psoriasis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06122649 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 21 locations. Find a study site near you:

Clinical Research Site

Beijing, Beijing Municipality 100034 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing Municipality 100191 - China

Status: Contact for availability

Clinical Research Site

Fuzhou, Fujian 350000 - China

Status: Contact for availability

Clinical Research Site

Guangzhou, Guangdong 510091 - China

Status: Contact for availability

Clinical Research Site

Shijiazhuang, Hebei 050000 - China

Status: Contact for availability

Clinical Research Site

Nanyang, Henan 473002 - China

Status: Contact for availability

Clinical Research Site

Yichang, Hubei 443003 - China

Status: Contact for availability

Clinical Research Site

Changsha, Hunan 410011 - China

Status: Contact for availability

Clinical Research Site

Suzhou, Jiangsu 215006 - China

Status: Contact for availability

Clinical Research Site

Wuxi, Jiangsu 241023 - China

Status: Contact for availability

And 11 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Plaque Psoriasis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships